Table 5 Comparison of trial characteristics across the real and synthetic datasets
From: A method for generating synthetic longitudinal health data
|  | Real n = 75,660 | Synthetic n = 75,660 | SMD |
|---|---|---|---|
Age | Â | Â | 0.078 |
 Mean (SD) | 43.32 (17.87) | 44.79 (19.83) |  |
 Median (IQR) | 42.00 [27.00] | 43.00 [30.00] |  |
Sex n (%) | Â | Â | 0.029 |
 Male | 38,623 (51.0) | 39,711 (52.5) |  |
 Female | 37,037 (49.0) | 35,949 (47.5) |  |
Elixhauser | Â | Â | 0.055 |
 Mean (SD) | 0.96 (1.58) | 1.05 (1.63) |  |
 Median (IQR) | 0.00 [1.00] | 0.00 [2.00] |  |
ALT | Â | Â | 0.099 |
 Mean (SD) | 31.67 (63.90) | 40.72 (111.92) |  |
 Median (IQR) | 24.00 [18.00] | 26.00 [19.00] |  |
eGFR | Â | Â | 0.112 |
 Mean (SD) | 85.82 (23.56) | 83.11 (25.05) |  |
 Median (IQR) | 87.00 [41.00] | 84.00 [38.00] |  |
HCT | Â | Â | 0.291 |
 Mean (SD) | 0.42 (0.05) | 0.41 (0.06) |  |
 Median (IQR) | 0.42 [0.05] | 0.41 [0.06] |  |
CACS-RIW | Â | Â | 0.002 |
 Mean (SD) | 0.05 (0.07) | 0.05 (0.07) |  |
 Median (IQR) | 0.03 [0.03] | 0.03 [0.03] |  |
RIW | Â | Â | 0.002 |
 Mean (SD) | 1.40 (2.73) | 1.40 (2.40) |  |
 Median (IQR) | 0.77 [0.82] | 0.81 [0.84] |  |
Opioid Utilization (%) | |||
 Morphine | 1758 (2.3) | 2649 (3.5) | 0.070 |
 Oxycodone | 73,902 (97.7) | 73,011 (96.5) |  |
Antidepressant Use | 28,224 (37.3) | 29,651 (39.2) | 0.039 |